19 March 2026: The Boots Group, a trusted leader in healthcare, pharmacy and retail, has announced the publication of its Environmental, Social and Governance (ESG) Report 2025: “We have health at our heart”.
The Boots Group’s ESG Report is the first it has published since the formation of the company, following the acquisition of Walgreens Boots Alliance by Sycamore Partners in August 2025. It highlights how ESG has been deeply embedded into all businesses across The Boots Group and showcases its continued progress towards supporting better health for people and the planet.
Ornella Barra Chair of the Board of Directors and Chair of the ESG Committee, The Boots Group, said: “Although this is our first ESG Report as The Boots Group, our business has been reporting on our progress for more than 60 years. Our longstanding commitment to supporting better health for people and planet is as strong as ever. Over the last 12 months, our progress has been significant. At the heart of our business is our role as a trusted healthcare partner within communities - supported by 66,000 colleagues in over 3,300 stores, we have delivered over a billion customer and patient interactions. That is why this year’s report is titled ‘We have health at our heart’.”
The full report features ESG milestones for The Boots Group during the financial year ending in August 2025 across its four key ESG Pillars – Healthy Communities, Healthy and Inclusive Workplace, Sustainable Marketplace and a Healthy Planet. Key highlights include:
Boots pharmacies delivered over 1.5 million NHS Pharmacy First consultations, and 497,000+ free Health MOTs to improve access to care and support NHS capacity.
The Boots Group contributed £53 million to support local communities through product and in-kind donations, volunteering and fundraising. This included to charity partners such as Macmillan Cancer Support, Irish Cancer Society, Hygiene Bank and The King’s Trust.
Boots was recognised through Henpicked’s Long Term Impact Honour for leadership as a menopause friendly employer.
No7 Beauty Company advanced its use of recycled content by moving over 120 product lines to a composition of 70% post-consumer recycled (PCR) material.
Across the Boots Group, 1,000+ own brand products are now certified cruelty free under the Leaping Bunny programme.
The Boots Group achieved a 37.1% reduction in Scope 1 and 2 carbon emissions versus a 2019 baseline, exceeding the company’s 2030 target.
Over 11 million hard to recycle items were diverted from landfill through Recycle at Boots.
The Boots Group ESG Impact Report is complemented by the ESG Technical Report 2025, which provides detailed performance data, governance disclosures and alignment with industry standards – Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB) Standards and Taskforce on Climate-related Financial Disclosures (TCFD) frameworks and is assured on a limited basis by Deloitte LLP.
Further information on ESG Initiatives at The Boots Group, its ESG Impact Report 2025 and ESG Technical Report 2025 are available at: Environmental Social and Governance
-ENDS-
For more information, please contact media.enquiries@boots.co.uk
About The Boots Group
The Boots Group includes pharmacy-led health and beauty retail businesses globally, along with a pharmaceutical wholesale operation in Germany. Through trusted brands, including Boots, No7 Beauty Company and Farmacias Benavides, the company focuses on helping people look and feel their best by delivering convenient high-quality healthcare and retail services. The Boots Group’s pharmaceutical wholesale business in Germany operates under the Alliance Healthcare Deutschland and GEHE brands, and supports over 11,000 pharmacies nationwide through modern logistics and digital healthcare services.